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Background: Achieving choice is proposed as a quality marker. But little is known about what influences preferences
especially among older adults. We aimed to determine and compare, across three countries, factors associated with
preferences for place of death and treatment, and actual site of death.
Methods: We recruited adults aged ≥65-years from hospital-based multiprofessional palliative care services in London,
Dublin, New York, and followed them for >17 months. All services offered consultation on hospital wards, support for
existing clinical teams, outpatient services and received funding from their National Health Service and/or relevant
Insurance reimbursements. The New York service additionally had 10 inpatient beds. All worked with and referred patients
to local hospices. Face-to-face interviews recorded most and least preferred place of death, treatment goal
priorities, demographic and clinical information using validated questionnaires. Multivariable and multilevel analyses
assessed associated factors.
Results: One hundred and thirty eight older adults (64 London, 59 Dublin, 15 New York) were recruited, 110 died
during follow-up. Home was the most preferred place of death (77/138, 56%) followed by inpatient palliative care/
hospice units (22%). Hospital was least preferred (35/138, 25%), followed by nursing home (20%) and home (16%);
hospice/palliative care unit was rarely least preferred (4%). Most respondents prioritised improving quality of life, either
alone (54%), or equal with life extension (39%); few (3%) chose only life extension. There were no significant
differences between countries. Main associates with home preference were: cancer diagnosis (OR 3.72, 95% CI
1.40–9.90) and living with someone (OR 2.19, 1.33–3.62). Adults with non-cancer diagnoses were more likely
to prefer palliative care units (OR 2.39, 1.14–5.03). Conversely, functional independence (OR 1.05, 1.04–1.06)
and valuing quality of life (OR 3.11, 2.89–3.36) were associated with dying at home. There was a mismatch between
preferences and achievements – of 85 people who preferred home or a palliative care unit, 19 (25%) achieved their
first preference.
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Conclusion: Although home is the most common first preference, it is polarising and for 16% it is the least
preferred. Inpatient palliative care unit emerges as the second most preferred place, is rarely least preferred,
and yet was often not achieved for those who wanted to die there. Factors affecting stated preferences and
met preferences differ. Available services, notably community support and palliative care units, require expansion.
Contrasting actual place of death with capacity for meeting patient and family needs may be a better quality indicator
than simply ‘achieved preferences’.
Keywords: Palliative care, End-of-life care, Preferences, Place of death, Home, Hospice, Hospital, Ageing, ElderlyBackground
Good health care should respond to individual views and
preferences; the unique things about a person. Recent pol-
icies in many countries centre on meeting choice and pref-
erences, such as the recent UK Choice Review [1] and the
US House Bill 5555, “Personalize Your Care Act of 2016”
[2]. One important component of choice in end-of-life care
is place of care and death [1–3]. This is also essential for
service planning – to ensure that the right services are de-
veloped to provide care, and to understand the large varia-
tions between and within countries [4–6]. Surveys and
prioritisation research show that most people with ad-
vanced illness want to die at home, although an important
minority prefers other locations [3, 7, 8]. However, the
probability of home death diminishes with age [6]. This
has important implications as, across the globe, popula-
tions are ageing rapidly, with more deaths at older ages [9].
Future projections indicate that home deaths may reduce,
rather than increase [10]. Some evidence suggests home
death is not preferred among older people, [11] other
studies contradict this and research is scant, [3, 7] des-
pite the fact that most people who die are aged over
65 years. As a result, several bodies have recommended
a move away from measuring home death rates as a
quality indicator, proposing ‘achieving a preference’ as a
better quality indicator, while acknowledging that it is
difficult to measure [12, 13].
A relatively large body of research has estimated factors
associated with actual place of death [14, 15]. Diversely lit-
tle is known about factors associated with preferences for
place of death. Research in different countries suggests
that preferences are constant for 70–90% [8, 16–18].
There are anecdotal reports of adults who do change their
preferences and qualitative studies have found that posi-
tive and negative experiences of care can alter preference
for place of death [19]. Without a better understanding of
factors influencing preferences for place of death, ‘achiev-
ing a preference’ risks being a flawed and misleading qual-
ity indicator. Preferences are more nuanced than a simple
‘first choice’; understanding what is least preferred is fun-
damental when developing appropriate quality indicators;
‘least preferred’ may not simply be the reverse of ‘most
preferred’ [20].This study aimed to determine the associates with the
most and least preferred place of death, treatment prior-
ities and whether these are similar to or different from the
associates with actual place of death across three countries
with developed specialist palliative care. We focused on
people aged 65 years and older because they are at highest
risk of dying, rising rapidly in population, and the least
studied. Secondary aims were to: describe and explore the
similarities and differences between individuals and their
preferences and priorities receiving palliative care in the
three countries. Given the differences in culture, health
care funding systems and eligibility for palliative care and
hospice services we hypothesised that this might lead to
differences in preferences, for example favouring treat-
ment to increase quantity rather than quality of life, or
preference for palliative or hospice care.
Methods
Study design and approvals
This prospective cohort study was part of the Build-
CARE programme to investigate access, care experience,
outcomes and their determinants for older people with
advanced diseases. We recruited older adults receiving
inpatient and outpatient multidisciplinary palliative care.
We enrolled consecutive consenting adults aged 65 years
and older from inpatient and outpatient palliative care
programs and subsequently recorded information about
where they died. The study received ethical approval
from relevant bodies (see declarations for details). Find-
ings are reported following STROBE and MORECARE
statements [21].
Setting
The study was conducted in the largest cities in the UK,
Ireland, and the USA: London, Dublin, and New York
City, respectively. Participating hospitals were: King’s
College Hospital and Guy’s and St Thomas’ Hospital in
London; Mater Misericordiae University Hospital and
Beaumont Hospital in Dublin; and Mount Sinai Hospital
in New York City. All participating hospitals have well-
developed specialist palliative care services and are able
to refer dying patients to local community hospices (with
inpatient beds, day care and community palliative care
Higginson et al. BMC Geriatrics  (2017) 17:271 Page 3 of 14programs). In addition, Mount Sinai Hospital operates an
inpatient palliative care unit within the acute care hospital
(Table 1). The London and Dublin hospital palliative care
teams are funded and managed by the corresponding
National Health Service, which is free at the point of
delivery. Palliative care from the New York team is cov-
ered by most insurance agencies and Medicare and Me-
dicaid. In all services and settings, additional charitable
support is needed for components (Table 1).
Procedures
Identification and recruitment
We screened consecutive adults accessing specialist pal-
liative care for >24 h. Inclusion criteria were English-
speaking and aged ≥65 years. In the first instance, clini-
cians (usually doctors but also clinical nurse specialists
and others caring for patients in palliative care teams)
explained the study. If individuals were agreeable to be-
ing approached, a researcher fully explained the study to
them, provided an information sheet and gained written
informed consent. Adults unable to give informed con-
sent or deemed too ill to complete any part of the inter-
view were excluded. This assessment occurred in two
stages, first the clinicians (doctors or nurses) in the pa-
tients immediate care team were able to indicate if they
felt a patient lacked capacity or was too ill or distressed
to be approached. In this instance the research team did
not approach them. The situation was reviewed after a
few days in case any of the issues (such as distress) less-
ened and patients could then be approached. In a small
number of instances clinicians gained approval for the
research team to approach patients, but when the re-
searcher visited they deemed that the patient lacked cap-
acity or was too ill to be approached. In these instances,
if they felt that the situation might be reversed, they
would arrange to re-contact the patient. The process re-
quired close working between the research teams and
clinicians and considerable flexibility by the researchers.
The project employed dedicated research staff to inter-
view patients in their place of choice. Most clinicians
raised the study in their regular (usually daily) multidis-
ciplinary team meetings and considered who may be eli-
gible, and agreed which team member would ask the
patient. The research team was on hand to quickly ap-
proach (usually the same or following day) patients who
might be willing to take part. This is essential for very ill
populations. Patients had at least 24 h to decide whether
to take part in the study. Mental capacity was assessed
and if possible improved to allow participation using
country-specific guidance. For example in the UK we
used, the Mental Capacity Act (MCA) and MCA guid-
ance [22], and equivalent procedures in line with re-
quirements in the US and Ireland, and the MORECARE
ethics recommendations [23]. Ethical and data protectionapprovals do not give consent to collect individual reasons
for not being offered the study by clinicians, however local
audits indicate that the main reasons were: 1) patients be-
ing too unwell as judged by the clinicians or family, usu-
ally due to physical symptoms e.g. in severe pain. In these
instances if symptoms were resolved individuals were re-
approached; 2) cognitive impairment or capacity issue,
often because patients were semi or unconscious, or
lacked mental capacity due to their illness; and 3) too dis-
tressed, as indicated by high levels of anxiety or depres-
sion. For symptom distress, if issues improved individuals
were re-approached.Questionnaire
The questionnaire was administered in a face-to-face inter-
view with a trained researcher or research nurse. It asked
about demographic and clinical information, symptoms
and palliative problems in the last 3 days (Palliative care
Outcome Scale (POS) [24]), functional status (Barthel
Index [25]), cognitive function (Short Orientation Memory
and Concentration Test (SOMCT) [26]) and services re-
ceived. It enquired about priorities and preferences for
care, using the format of a major European survey [27, 28].
Questions about most and least preferred place of
death were: “If you were in a situation of serious illness
with limited time to live, what do you think you would
prefer if circumstances allowed you to choose? / What
do you think you would least prefer if circumstances
allowed you to choose?” Response options were: In your
own home, in the home of a relative or friend, in a pal-
liative care unit or hospice (the common term for an in-
patient palliative care unit in the UK and Ireland), in a
nursing home, in a residential home, somewhere else,
don’t know, or refusal/prefer not to say.
Questions were asked about treatment goal priorities
and decision making, in a scenario of serious illness.
This included asking: “In situations of serious illness
with limited time to live difficult decisions may need to
be made and some things may need to be prioritised
over others. In this situation, would it be more import-
ant to:” (three options were given to choose from) ex-
tend your life; improve the quality of life for the time
you had left; or both are equally important? It also
asked:
“Who would you like to make decisions about your
care? Please choose as many as apply, you can choose
more than one.” YES or NO was given to each of options:
yourself, your spouse or partner, other relatives, friends,
the doctor, others, don’t know, or refusal/prefer not to say.
The questionnaire used in London site is provided
(Additional file 1).
Clinical records were reviewed for clinical data; infor-
mation on adults who died was extracted. Records were
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from 17 to 39 months from study enrolment.
Statistical analysis
We calculated summary statistics using proportions and
means (standard deviation) and conducted ANOVA tests
for differences by city. We examined the distribution of
preferences (most and least preferred place of death) by
actual place of death and time to death after first referral
to specialist palliative care. Count of positive answer to
the delegation of decisions on care was compared with
the preferences. Our primary dependent variable in re-
gression analyses was whether or not home was the
most preferred place of death. Other dependent variables
were: least preferred place of death, preference for in-
patient hospice/palliative care unit and the actual place
of death (to see if these were similar). As an auxiliary
examination, we checked the propensity of dying in indi-
viduals with different preferences.
We selected potential explanatory variables based on
the model developed from results of an international
systematic review including over 1.5 million adults, [15]
and the availability of the variables: sociodemographic
(age, gender, living with others, availability of primary
carer, financial status); clinical (diagnosis (cancer or
not)), palliative care outcomes (POS total score), func-
tional status (Barthel Index score [25]), cognitive func-
tion (SOMCT score [26]); and treatment priorities for
quantity and/or quality of life [27]. We used correlations
among potential explanatory variables, results from uni-
variate regression analysis and Akaike information criter-
ion (AIC), [29] to choose the final set of explanatory
variables for the multivariate regression models [30].
To see if death within 30 days of referral to palliative
care was associated with outcome variables, regression
analysis was conducted. We also conducted regression
analysis with each of the delegation of care decision op-
tions, as a dichotomous variable in the model.
Due to the sampling structure (i.e. whether partici-
pants from one site e.g. London may have different char-
acteristics to others), we conducted multilevel analysis
and used the multivariate logistic regression model with
site level fixed effects and a robust variance estimate
adjusted for within-site correlation. Our main analysis
used complete cases. Missing variables were explored
using summary statistics and regression analysis. We
conducted two sets of sensitivity analyses. The first set
excluded the small number who selected the home of a
friend as least preferred while choosing own home as
most preferred. The second set used the full information
maximum likelihood estimation [31] to impute missing
values. STATA version 13.1 was used for all analyses.
We estimated that a sample of 130 participants would
enable us to enter 10–12 variables in regression analysis.It also enables us to detect a 17% difference between
countries in terms of preferences or actual place of death
(taking a conservative comparison of 60% v 43% at
p < 0.05, power 80%), and estimate the proportion with
different preferences with a conservative margin of error
of <9%.Results
Recruitment and characteristics
We recruited 163 adults: 70 in London, 70 in Dublin
and 23 in New York. Thirty-five adults completed only
early demographic data and were too ill to complete the
latter part of the questionnaire, including the preferences
questions. Thus, 138 (64 in London, 59 in Dublin and
15 in New York) were used for the analysis.
Average age was 74 years. New York had more women
than London and Dublin. Eighty-eight percent had can-
cer: genitourinary cancer and digestive cancer was the
most common in London, genitourinary cancer in
Dublin, digestive cancer in New York. Forty-two percent
in London and 59% in Dublin and 53% in New York
lived with someone, 76% had a primary caregiver, 35%
were living comfortably, 48% coping, and 12% had diffi-
culties on present income (Table 2). Missing data were
small and mostly due to illness and/or fatigue. About
8.7% and 5.0% of the sample had missing values on
Barthel and SOMCT scales respectively.
Participants in New York appeared more functionally in-
dependent (mean Barthel score: 94.3) than participants in
Dublin (75.8) and London (69.5) (p < 0.01; Barthel score
61–90 suggests moderate dependence and 91–99 slight de-
pendence) [25]. Correspondingly, participants in London
(SOMCT score: 11.3) and Dublin (10.8) had lower level of
cognitive function, compared with participants in New
York (SOMCT score: 7.8, p < 0.07). Participants in London
had more severe symptoms and problems as measured by
POS score (13.3) than in New York (10.1) and Dublin (8.1,
p < 0.01) (Table 2). Other characteristics did not differ by
city. As of end January 2016, 110 participants were con-
firmed to have died, 15 (11%) were alive; information miss-
ing for 13 (9%). Median survival was 146 days.Preferences
Most respondents (133/138, 96%) declared preferences
regarding treatment priorities, 123/138 (89%) declaring a
most preferred place of death and 114/138 (83%) declar-
ing a least preferred place of death.
When asked about treatment priorities in serious ill-
ness with limited time to live, only 3% (three people in
Dublin, one in London, none in New York) answered
that extending their life would be more important than
its quality. Most chose one of the other two options, ei-
ther ‘improving the quality of life for the time left’ (54%)
Table 2 Characteristics of recruited participants (unit: %, mean (sd))
London Dublin New
York
All
(N = 64) (N = 59) (N = 15) (N = 138)
Female 47% 44% 80% 49%
Age (years)
65–69 31% 34% 33% 33%
70–74 25% 27% 33% 27%
75–79 20% 19% 20% 20%
80–89 16% 17% 13% 21%
90–96 8% 3% 0% 5%
Diagnosis
Lung and respiratory
cancer
8% 14% 13% 11%
Breast cancer 11% 8% 13% 10%
Genitourinary cancer 25% 27% 7% 24%
Haematological cancer 8% 3% 20% 7%
Digestive cancer 25% 24% 27% 25%
Ill-defined cancer 3% 8% 0% 5%
Other cancer 8% 2% 13% 6%
Non-cancer respiratory 3% 2% 0% 2%
Non-cancer circulatory 5% 7% 0% 5%
Non-cancer CNS 2% 3% 0% 2%
Renal failure 0% 0% 7% 1%
Other non-cancer 3% 2% 0% 2%
Total Cancer (=1 if cancer) 88% 86% 93% 88%
Marital status
Single 13% 14% 20% 14%
Widowed 31% 36% 13% 31%
Married/civil partnership 33% 42% 53% 39%
Divorced/separated 23% 8% 13% 16%
Living with
(=1 if with someone else)
42% 59% 53% 51%
Primary carer (=1 if available) 78% 73% 80% 76%
Household income
Living comfortably on
present
36% 32% 40% 35%
Coping on present 45% 54% 33% 48%
Difficult on present 16% 7% 13% 12%
Very difficult on present 3% 7% 7% 5%
Prefer not to say 0% 0% 7% 1%
Religion (=1 if religious) 67% 76% 80% 72%
Palliative concerns POSa
total score**
13.3 (6.3) 8.1 (5.5) 10.1
(4.7)
10.7 (6.3)
Barthel Indexb total score** 69.5
(24.5)
75.8
(26.1)
94.3
(9.6)
75.2
(25.1)
SOMCTc total score 11.3 (5.3) 10.8 (4.4) 7.8 (2.4) 10.8 (4.8)
Table 2 Characteristics of recruited participants (unit: %, mean (sd))
(Continued)
London Dublin New
York
All
(N = 64) (N = 59) (N = 15) (N = 138)
Participant died as of end January 2016**
Yes 86% 88% 20% 80%
No 9% 2% 53% 11%
Don’t know 5% 10% 27% 9%
Died within 30 days after
referral to palliative care
9% 10% 7% 9%
**p < 0.01 according to the ANOVA tests for differences among the three sites
aPOS = Palliative care Outcome Scale score, a higher score is worse
bBarthel Index score, 0–20 suggests total dependence, 21–60 severe
dependence, 61–90 moderate dependence, 91–99 slight dependence and 100
indicates that a patient is independent of assistance from others [25]
cSOMCT = Short Orientation Memory and Concentration Test score, a higher
score is worse
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(39%, but highest in New York: 47%, Table 3).
Most and least preferred place of death and whether
preferences were met
Home was the most common preferred place of death:
56% overall (Table 3). Palliative care unit was the second
most preferred (22%). There were no significant differ-
ences between cities, but this was highest in New York
(33%). The least preferred place for death was in hospital
outside of a palliative care unit (25%), followed by nursing
or residential home (19%) and own home (16%). Nobody
selected the home of a family or friend as their most pre-
ferred place of death; six participants (4%) chose their
own home as the most preferred place of death and simul-
taneously another’s home as the least preferred place of
death (Additional file 2: Appendix Table A1).
Of the 110 adults who died we were able to confirm
place of death for 103. Of these 40 died in a palliative
care unit, 35 in hospital, 22 at home and six in a nurs-
ing/residential home.
Of 62 participants with a known place of death and who
had stated their preference was to die at home, 14 (23%)
achieved this. Most (26, 42%) died in a palliative care unit.
Many died in hospital (19, 31%), often their least preferred
place of death (Table 4, Fig. 1). Of the 23 adults who had
preferred a palliative care unit, five (23%) achieved this
(Table 4). Most of the deaths in palliative care units were
people who would have preferred home. Conversely, al-
though 35 older adults died in hospital, this was the pre-
ferred place of death for only one (3%). Thirteen adults
died at the place which they least preferred, the highest
number was in hospital, where eight out of 26 (31%) who
had least preferred hospital died there.
A palliative care unit was rarely least preferred (by
only six (4%) respondents, Table 3). Of the 40 people
Table 3 Preference for place of death, treatment priorities and
decision making
London Dublin New York All
(N = 64) (N = 59) (N = 15) (N = 138)
Most preferred place of death1
Home 42
66%
28
47%
7
47%
77
56%
Home of a relative or
friend
0
0%
0
0%
0
0%
0
0%
Palliative care unit
or inpatient hospice
12
19%
14
24%
5
33%
31
22%
Hospital 2
3%
4
7%
0
0%
6
4%
Nursing home or
residential home
1
2%
2
3%
0
0%
3
2%
Elsewhere 4
6%
1
2%
1
7%
6
4%
Don’t know/prefer
not to say
3
5%
10
17%
2
13%
15
11%
Least preferred place
of death2
Home 8
13%
10
17%
4
27%
22
16%
Home of a relative
or friend
9
14%
3
5%
0
0%
12
9%
Palliative care unit
or inpatient hospice
5
8%
1
2%
0
0%
6
4%
Hospital 18
28%
15
25%
2
13%
35
25%
Nursing home or
residential home
17
27%
6
10%
4
27%
27
20%
Somewhere else 1
2%
8
14%
2
13%
11
8%
Don’t know/prefer
not to say
6
8%
16
27%
3
20%
25
18%
Treatment goal priority:
quantity or quality of lifea3
To extend life 1
2%
3
5%
0
0%
4
3%
To improve the quality
of life for time left
38
59%
30
51%
6
40%
74
54%
Both are equally
important
23
36%
24
41%
7
47%
54
39%
Don’t know/prefer not
to say
2
3%
2
3%
2
13%
5
4%
Person who makes
decisions about careb4
Herself/himself 62
97%
48
81%
10
67%
120
87%
Spouse or partner 22
34%
17
29%
2
13%
41
30%
Other relatives 37
58%
31
53%
7
47%
75
54%
Friends 6
9%
0
0%
1
7%
7
5%
Table 3 Preference for place of death, treatment priorities and
decision making (Continued)
London Dublin New York All
(N = 64) (N = 59) (N = 15) (N = 138)
The doctor 18
28%
11
19%
0
0%
29
21%
Notes: a The exact question used: “In situations of serious illness with limited
time to live difficult decisions may need to be made and some things may need
to be prioritized over others. In this situation, would it be more important to
extend your life or to improve the quality of life for the time you had left or are
both equally important?”
Statistical test for the difference among countries was conducted using log-
likelihood ratio test, adjusting for age, gender and cancer/non-cancer. b The
exact question: “Who would you like to make decisions about your care? Please
choose as many as apply, you can choose more than one.” All but one respondent
chose at least one option
1Test for difference: Χ2=7.77 (df = 14), p < 0.9009
2Χ2=18.58 (df = 18), p < 0.4183
3Χ2=6.25 (df = 8), p < 0.6187
4Χ2=12.62 (df = 2), p < 0.0018; Χ2=2.04 (df = 2), p < 0.3609; Χ2=1.68 (df = 2),
p < 0.4323; Χ2=8.00 (df = 2), p < 0.0183; Χ2=8.57 (df = 2), p < 0.0138
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for only one (Table 4).
Factors associated with home as the most preferred place
of death
Participants with cancer (OR 3.72, 95% CI 1.40–9.90) or liv-
ing with somebody else (OR 2.19, 95% CI 1.33–3.62) were
more likely to prefer their home as a place of death to other
places. Adults with higher Barthel scores of functional inde-
pendence were marginally less likely to prefer home as a
place of death (OR 0.99, 95% CI 0.98–1.00; note CI reaches
1 due to rounding). Age was not associated with any most
preferred place of death. When we asked about the least
preferred place of death, non-cancer was associated with
home as a least preferred place of death (OR 4.29, 95% CI
1.23–15.00) (Table 5). Sensitivity analysis, excluding those
who chose another’s home as the least preferred choice,
found the same results, except that effects of cancer
was statistically significant (cancer patients were less
likely to least prefer home).
Factors associated with palliative care unit (inpatient
hospice) as the most preferred place of death
Participants with non-cancer diagnosis (OR 2.39, 95%
CI 1.14–5.03) or higher SOMCT scores (OR 1.09,
95% CI 0.97–1.23) were more likely to choose pallia-
tive care unit/inpatient hospice as the most preferred
place of death (Table 5).
Propensity of mortality among samples
Having cancer was associated with dying sooner, but con-
fidence intervals were wide (OR 9.3, 95% CI 1.5–57.8).
There were no consistent patterns of other factors associ-
ated with dying sooner in sensitivity analysis. (Additional
file 2: Appendix Table S4). Those preferring death at home
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Fig. 1 Least preferred and actual place of death for those people who declared they most preferred to die at home (N = 77)
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ferred elsewhere (Additional file 2: Appendix Table S2 and
Additional file 2: Figure S1).Factors associated with actual place of death
No sample from New York was used in this analysis due
to small numbers. Age, diagnosis and living status were
not significant in the analysis. Higher functional independ-
ence (OR 1.05, 95% CI 1.04–1.06) was associated with
greater likelihood of dying at home. Participants who val-
ued only quality of life (OR 3.11, 95% CI 2.89–3.36) were
more likely to die at home than those who valued bothTable 5 Multivariate logistic regression: factors associated with a pre
Home as the most preferred Home as the least pr
Odds ratio CI Lower CI Upper Odds ratio CI Lower
Female 0.53 0.11 2.51 1.81 0.93
Age (base: 65–69)a
70–79 0.95 0.13 6.82 1.48 0.56
80–96 0.77 0.49 1.23 1.71 0.66
Cancer 3.72** 1.40 9.90
Non-cancer 4.29* 1.23
Living with 2.19** 1.33 3.62 1.02 0.32
Barthel total score 0.99** 0.98 1.00 1.03 0.98
28-SOMCT total score
Constant 2.42** 1.86 3.13 0.01* <0.00
N 113 102
Log likelihood −67.16 −45.71
**p < 0.01 and *p < 0.05. Standard errors are adjusted for 3 clusters in Site. Site leve
aJoint test for age categories was: Χ2 = 3.18 (df = 2), p < 0.2.43; Χ2 = 1.21 (df = 2), pquality and extension of life (Additional file 2: Appendix
Table S5).
Relationships with delegation of decisions on care
87% positively answered they would like to make deci-
sions on care, 30% for spouse or partner, 54% for other
relatives, 5% for friends and 21% for the doctors them-
selves (Table 3). In regression analysis, wanting a
spouse/partner to make decisions was associated with
preference for home (OR 1.92 95% CI 1.42–2.59); opting
for friends was associated with preference for palliative
care unit/hospice (OR 4.05 95% CI 1.24–13.18); and
choosing a spouse/partner or friends with actual homeference for home or inpatient hospice/palliative care unit
eferred Palliative care unit or inpatient hospice as the most preferred
CI Upper Odds ratio CI Lower CI Upper
3.51 1.68 0.21 13.87
3.91 1.30 0.11 14.81
4.47 1.79 0.40 8.05
15.00 2.39* 1.14 5.03
3.23
1.07 1.00 1.00 1.01
1.09* 0.97 1.23
0.52 0.02** <0.00 0.25
107
−54.92
l fixed effects model was estimated
< 0.5471; Χ2 = 5.89 (df = 2), p < 0.0527
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1.96–8.14) (Additional file 2: Appendix Table S3).
Discussion
In this first multi-centre study of the preferences of
older adults with advanced disease across in three coun-
tries, home was consistently the most preferred place
and hospital the least preferred place, with no differ-
ences between countries adjusting for age, gender and
cancer diagnosis. In the USA, patients had the highest
preference for hospital palliative care units – an option
not commonly available to those in the UK or Ireland,
where the closest option is usually an inpatient hospice.
Having a cancer diagnosis and living with someone else
were independently associated with preferring to die at
home. A preference for involving partners or spouses in
healthcare decisions was also associated with preferring
home. In contrast, diagnosis and living status were not
associated with place of death, and instead functional
status and preferring treatments aimed to improve qual-
ity of life were associated with dying at home.
Our data shed light on the more nuanced patterns of
choice around the end of life. Home appears to be a po-
larizing choice; it is definitely the choice of a majority,
but also interestingly the least favoured option of around
16%. Not having cancer was independently associated
with choosing home as least preferred. Reasons for this
may be related to perceived burden to others, [32] wish-
ing to feel safe, [11] failings in care continuity or coord-
ination [33] and the quality of support at home,
especially out-of-hours support [11, 19]. Further work is
needed to understand whether not wanting to die at
home is a positive choice, or a reaction against failures
in care [19]. Choice is complicated by cognitive biases,
such as forecasting errors and default options, that per-
vade human decision making [34]. For example, in these
choices, being unaware of, or having unrealistic forecasts
about the nature of home or hospital or palliative care
or the nature of the problems they or their family may
face are likely to influence the preferences expressed. In-
dividuals may also report the choice that they think is
the most socially acceptable to their family or friends or
which they think is the most common (default option).
They may also express the preference that they think
will leave them with the most remaining options should
that option fail. Data on the quality of care is vital here,
as home is only able to be a choice if services meet indi-
vidual needs and are of good quality. As Shakespeare
said in The Taming of the Shrew “There's small choice in
rotten apples.” Feeling unsafe at home is emerging as a
leading reason for people to seek care in hospital [35].
Our study is the first to show that the home of a rela-
tive or family member should not be considered as an
equal alternative to patients dying in their own home.We found a family member’s home was never the most
preferred, and was least preferred for almost 1 in 10.
Thus, dying in the house of family members or friends
should not be promoted as an alternative to dying at
home. Preferences for home are thought to be related to
a wish for familiar surroundings, flexible regime and
control [7]. The home of a family member may well not
meet these requisites, as well as leading to greater fear
of being a burden.
Our study found that general hospital wards were defin-
itely disliked by many: these were very rarely a preferred
choice and the least preferred for most. Similarly, nursing
homes were rarely favoured. Inpatient palliative care units
and hospices emerged as an important alternative to
home; these were the second most common preference
after home, and seem to be relatively acceptable as only 6
people (4%) considered these the least preferred option.
We were interested to see the high proportion from the
USA favouring this option. In the USA, as for the USA
site in this study, palliative care units are often designated
wards for the care of patients receiving palliative care
within hospitals. Thus, a palliative care unit or inpatient
hospice within a hospital appears to be a viable alternative,
at least as far as choice is considered. People with non-
cancer conditions were more likely to choose this option.
This diverges from provision in many countries: people
with non-cancer conditions have low access to inpatient
hospice or palliative care units [36–39]. We found that
most people who wanted to die at home actually died in a
palliative care unit or inpatient hospice. Indeed the group
wanting to die at home formed the majority dying in a
hospice or palliative care unit. Those wanting home were
more likely to die in a palliative care unit or hospice than
those people who had actually wanted to die in that set-
ting. This may be because many hospices prioritise trans-
fers from home, rather than from hospitals, and suggests
that the availability of inpatient hospice and palliative care
beds needs expansion. The cost effectiveness of home and
inpatient palliative care services is now being established,
further supporting these initiatives [40, 41]. With such ser-
vices the actual place of death can be more often at home
and in palliative care units, [42, 43] which our study sug-
gests would more closely meet patient choice.
In our study, while just over 50% of older patients pre-
ferred to die at home, patients’ deaths mainly occurred
elsewhere, with different factors associated with prefer-
ences and reality. Interventions that may help address
this disparity include advance care planning, as older
adults involved in some form of advance care planning
may be less likely to die in a hospital (adjusted relative
risk (aRR) = 0.87, 95% CI 0.80–0.94) [44]. National stud-
ies in both the UK and USA have also found that hos-
pital admission is driven by distressing symptoms [45]
with inadequate pain management for older people in
Higginson et al. BMC Geriatrics  (2017) 17:271 Page 11 of 14primary care [46] and nursing homes [47]. Trials of
cost-effective ways to alleviate symptoms and provide
high quality and safe care for older adults with advanced
disease in the community 24/7 are therefore urgently
needed.
Our finding of greater functional independence being
associated with a home death contradicts findings from a
major systematic review, although the review included
only those who died from cancer [15]. Adults with higher
levels of functional independence may feel that they are
less of a burden on their families. In addition, those with
more need for physical care may place a greater demand
on community resources, driving hospital admission [45].
However, we found a divergence from factors associated
with preferences, as those with higher functional inde-
pendence were marginally less likely to prefer home.
Taken together these findings suggest that use of ‘meet-
ing’ a preference as a quality indicator is limited. Across
all three countries the variation between most and least
preferred suggests that any quality indicator, rather than
focussing on meeting individual preferences alone, should
consider whether individual ‘least favoured’ preferences
were avoided, and should understand influencing factors.
It is vital also to assess the capacity to meet preferences in
that setting, including the quality of care, wherever care is
offered even when measurement is challenging [48]. The
quality of care can include controlling pain and symptoms
and addressing concerns, information and practical and
financial issues, such as measured in the Palliative care
Outcome Scale [49, 50]. It may also include financial hard-
ship, such as out of pocket expenses [51]. Recent research
has found an increase in emergency department use dur-
ing the last year of life, despite falling hospital deaths, for
people with both cancer [52] and dementia, [53] suggest-
ing that quality indicators need to consider a longer period
of time than only the point of death. The use of
population-based quality indicators, such as avoiding hos-
pitalisation, and care in and dying at home or in an in-
patient palliative care unit, are supported by our results
which found consistent patterns in these preferences.
Their use is valid at a population level, rather than at an
individual level as some aspects such as home is clearly
not favoured by an important proportion of the popula-
tion, although it is consistently the majority wish in all set-
ting and by all groups. There remains a marked gap
between the proportion that wish to be cared for at home
or in an inpatient palliative care unit and those who even-
tually die there, indicating that more resources are needed
in these settings.
A major strength of our study is that we successfully
included those with advanced diseases. Most research
about preferences is on the general population, whose
views may change following illness [7]. However, we may
have missed other individuals not receiving palliative care,some of whom may not have wanted such care, and con-
sequently may have different preferences. While the na-
ture of questions meant that those with cognitive
impairment were excluded from the study, this also makes
the results not generalizable to all older people. Few older
people with cognitive impairment, for example with de-
mentia, die in specialist palliative care units, and the ma-
jority die in long-term care facilities or in acute hospitals
[54]. Eighty-eight percent of participants had a cancer
diagnosis, most likely because the sample was from those
receiving specialist palliative care, although the focus of
specialist palliative care is changing and encompasses
more conditions. However, our results may have a skewed
view of preferences. It is well documented that those dying
from dementia and other chronic diseases have similar
end of life symptoms as those dying from cancer, although
with a different trajectory. Although our non cancer group
was small, it is important to note that non cancer was as-
sociated with a preference for in-patient hospice and pal-
liative care, despite this usually being little available. It
may be that in cases other than cancer, it is only those
individuals with very strong expressed preferences for hos-
pice and palliative care who can gain access. Further work
is needed among other broader samples of older people
with advanced illness, especially in non specialist palliative
care settings. If possible this should employ proxy or other
methods to understand preferences when people have
cognitive impairment.
We specifically asked individuals if they wished not to
state a preference, and/or if they did not know, and have
reported these data in our overall percentages, as recom-
mended [55]. Eleven percent of respondents opted not
to state a most preferred place of death, and 18% least
preferred. A King’s Fund population based survey found
that 75% of people said choice was either ‘very import-
ant’ or ‘important’ to them, [56] which would be consist-
ent with our results. In the King’s Fund survey, older
respondents were more likely to value choice if they
were with no qualifications and from a mixed or non-
white background [56]. More work is needed to under-
stand whether particular groups elect ‘no preference’,
whether a preference would have emerged over time,
whether it did not matter to respondents, or whether re-
spondents did not want to discuss the issue with the
interviewer. Finally, not all patients had died at the point
of follow-up, and so are missing from the place of
death analysis.
Conclusions
Home and palliative care unit were the most commonly
preferred place of death in all countries. In this sample,
having cancer and living with others are associated with
home preference. A non-cancer diagnosis was associated
with preference for a palliative care unit. Different factors
Higginson et al. BMC Geriatrics  (2017) 17:271 Page 12 of 14were associated with place of death than with preferences.
We propose that actual place of death and its fit to the
needs and preferences of patients and their families should
be measured when assessing the quality of end of life care.
Available services need to be improved to more closely
meet actual needs, for example by providing the 24/7 level
of community palliative care support needed to enable
home deaths, and further developing inpatient palliative
care units (in hospitals or freestanding hospices) while en-
suring access for those with non-malignant conditions.
The home of a relative or family member or a care home
should not be considered as an equal alternative to a per-
son’s own home.
Additional files
Additional file 1: Copy of the questionnaire. Questionnaire used in the
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